Patent details
92512
Product Name:
Afoxolaner, ou un oxyde nitrique de celui-ci, ou un sel pharmaceutiquement acceptable de celui-ci
Basic Information
- Publication number:
- 92512
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP068482637
- Legal Status:
- Inactive
- Application number:
- 92512
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/2/13/159
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 13/02/2014
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 05/08/2014
- First Marketing Authorization date:
- 13/02/2014
- Grant date:
- 06/10/2014
- Activation date:
- Publication date:
- 06/10/2014
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 13/02/2029
- SPC Extension Expiration:
- 13/02/2029
- Rejection date:
- Withdrawal date:
Owner
- From:
- 05/08/2014
-
-
- Name:
- E.I. DU PONT DE NEMOURS AND COMPANY
- Address:
- 1007 Market Street, Wilmington, DE 19898, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 05/08/2014
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- XU Ming
- Address:
- United States (US)
2
- Name:
- LAHM George, Philip
- Address:
- United States (US)
3
- Name:
- SHOOP Wesley, Lawrence
- Address:
- United States (US)
Publication
Bulletin
- Bulletin Heading:
- SPC4
- Bulletin edition number:
- 2023/12
- Publication date:
- 06/11/2023
- Description:
- Section F : Correction of granted supplementary protection certificates – I9 publication
Annual Fees
- Annual Fee Due Date:
- 31/12/2026
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-